Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 202

1.

Medication utilization and annual health care costs in patients with type 2 diabetes mellitus before and after bariatric surgery.

Makary MA, Clark JM, Shore AD, Magnuson TH, Richards T, Bass EB, Dominici F, Weiner JP, Wu AW, Segal JB.

Arch Surg. 2010 Aug;145(8):726-31. doi: 10.1001/archsurg.2010.150. Erratum in: Arch Surg. 2011 Jun;146(6):659. Clarke, Jeanne M [corrected to Clark, Jeanne M].

PMID:
20713923
[PubMed - indexed for MEDLINE]
2.

Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: a longitudinal cohort study.

Balkrishnan R, Rajagopalan R, Camacho FT, Huston SA, Murray FT, Anderson RT.

Clin Ther. 2003 Nov;25(11):2958-71.

PMID:
14693318
[PubMed - indexed for MEDLINE]
3.

Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.

Pawaskar MD, Camacho FT, Anderson RT, Cobden D, Joshi AV, Balkrishnan R.

Clin Ther. 2007 Jun;29(6 Pt 1):1294-305.

PMID:
18036391
[PubMed - indexed for MEDLINE]
4.

Health care costs associated with escalation of drug treatment in type 2 diabetes mellitus.

Brown JB, Nichols GA, Glauber HS, Bakst AW, Schaeffer M, Kelleher CC.

Am J Health Syst Pharm. 2001 Jan 15;58(2):151-7.

PMID:
11202539
[PubMed - indexed for MEDLINE]
5.

Utilization and costs for compliant patients initiating therapy with pioglitazone or rosiglitazone versus insulin in a Medicaid fee-for-service population.

Kalsekar I, Iyer S, Mody R, Rajagopalan R, Kavookjian J.

J Manag Care Pharm. 2006 Mar;12(2):121-9.

PMID:
16515370
[PubMed - indexed for MEDLINE]
Free Article
6.

Comparisons of rosiglitazone versus pioglitazone monotherapy introduction and associated health care utilization in Medicaid-enrolled patients with type 2 diabetes mellitus.

Balkrishnan R, Arondekar BV, Camacho FT, Shenolikar RA, Horblyuk R, Anderson RT.

Clin Ther. 2007 Jun;29(6 Pt 1):1306-15.

PMID:
18036392
[PubMed - indexed for MEDLINE]
7.

A comparison of insulin use, glycemic control, and health care costs with insulin detemir and insulin glargine in insulin-naive patients with type 2 diabetes.

Borah BJ, Darkow T, Bouchard J, Aagren M, Forma F, Alemayehu B.

Clin Ther. 2009 Mar;31(3):623-31. doi: 10.1016/j.clinthera.2009.03.005.

PMID:
19393853
[PubMed - indexed for MEDLINE]
8.

Healthcare costs and prescription adherence with introduction of thiazolidinedione therapy in Medicaid type 2 diabetic patients: a retrospective data analysis.

Balkrishnan R, Rajagopalan R, Shenolikar RA, Camacho FT, Whitmire JT, Anderson RT.

Curr Med Res Opin. 2004 Oct;20(10):1633-40. Erratum in: Curr Med Res Opin. 2005 Feb;21(2):323.

PMID:
15462696
[PubMed - indexed for MEDLINE]
9.
10.

[Cost of diabetes mellitus in Spain].

González P, Faure E, Del Castillo A; Grupo de Trabajo para el Estudio del Coste de la Diabetes.

Med Clin (Barc). 2006 Nov 25;127(20):776-84. Spanish. No abstract available.

PMID:
17198665
[PubMed - indexed for MEDLINE]
11.

Comparison of costs among patients with type 2 diabetes treated with exenatide or sitagliptin therapy.

Lage MJ, Fabunmi R, Boye KS, Misurski DA.

Adv Ther. 2009 Feb;26(2):217-29. doi: 10.1007/s12325-009-0002-0. Epub 2009 Feb 14.

PMID:
19219409
[PubMed - indexed for MEDLINE]
12.

Health care costs and medication adherence associated with initiation of insulin pen therapy in medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.

Pawaskar MD, Camacho FT, Anderson RT, Cobden D, Joshi AV, Balkrishnan R.

Clin Ther. 2007;29 Spec No:1294-305.

PMID:
18046929
[PubMed - indexed for MEDLINE]
13.

Direct medical costs for type 2 diabetes mellitus complications in the US commercial payer setting: a resource for economic research.

Pelletier EM, Smith PJ, Boye KS, Misurski DA, Tunis SL, Minshall ME.

Appl Health Econ Health Policy. 2008;6(2-3):103-12. doi: 10.2165/00148365-200806020-00003.

PMID:
19231904
[PubMed - indexed for MEDLINE]
14.

Determinants of diabetes-attributable non-blood glucose-lowering medication costs in type 2 diabetes: the Fremantle Diabetes Study.

Davis WA, Knuiman MW, Hendrie D, Davis TM.

Diabetes Care. 2005 Feb;28(2):329-36.

PMID:
15677788
[PubMed - indexed for MEDLINE]
15.

A comparison of costs among patients with type 2 diabetes mellitus who initiated therapy with exenatide or insulin glargine.

Misurski D, Lage MJ, Fabunmi R, Boye KS.

Appl Health Econ Health Policy. 2009;7(4):245-54. doi: 10.2165/11318730-000000000-00000.

PMID:
19905038
[PubMed - indexed for MEDLINE]
16.

Economic impact of the clinical benefits of bariatric surgery in diabetes patients with BMI ≥35 kg/m².

Klein S, Ghosh A, Cremieux PY, Eapen S, McGavock TJ.

Obesity (Silver Spring). 2011 Mar;19(3):581-7. doi: 10.1038/oby.2010.199. Epub 2010 Sep 9.

PMID:
20829800
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

The association of insulin medication possession ratio, use of insulin glargine, and health benefit costs in employees and spouses with type 2 diabetes.

Kleinman NL, Schaneman JL, Lynch WD.

J Occup Environ Med. 2008 Dec;50(12):1386-93. doi: 10.1097/JOM.0b013e3181875e9b.

PMID:
19092494
[PubMed - indexed for MEDLINE]
18.

Cost-effectiveness of surgically induced weight loss for the management of type 2 diabetes: modeled lifetime analysis.

Keating CL, Dixon JB, Moodie ML, Peeters A, Bulfone L, Maglianno DJ, O'Brien PE.

Diabetes Care. 2009 Apr;32(4):567-74. doi: 10.2337/dc08-1749. Epub 2009 Jan 26.

PMID:
19171720
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Bariatric surgery: cost-effectiveness and budget impact.

Terranova L, Busetto L, Vestri A, Zappa MA.

Obes Surg. 2012 Apr;22(4):646-53. doi: 10.1007/s11695-012-0608-1. Review.

PMID:
22290621
[PubMed - indexed for MEDLINE]
20.

Outcomes associated with introduction of thiazolidinedione therapy in Medicaid enrolled patients with type 2 diabetes: an updated and expanded retrospective analysis.

Balkrishnan R, Rajagopalan R, Shenolikar RA, Camacho FT, Anderson RT.

Curr Med Res Opin. 2006 Mar;22(3):551-9.

PMID:
16574038
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk